Met Life Investment Management, LLC Cyclerion Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$1.8 - $13.43 $22,689 - $169,285	-12,605 Closed	0 $0
Q3 2019 Jul 12, 2023	BUY	$8.12 - $14.54 $102,352 - $183,276	12,605 New	12,605 $152,000
Q3 2019 Mar 22, 2023	BUY	$8.12 - $14.54 $50,644 - $90,685	6,237 Added 97.94%	12,605 $152,000
Q3 2019 Nov 14, 2019	BUY	$8.12 - $14.54 $50,644 - $90,685	6,237 Added 97.94%	12,605 $153,000
Q2 2019 Jul 12, 2023	BUY	$9.6 - $22.85 $121,008 - $288,024	12,605 New	12,605 $144,000
Q2 2019 Mar 22, 2023	BUY	$9.6 - $22.85 $61,132 - $145,508	6,368 New	6,368 $72,000
Q2 2019 Aug 14, 2019	BUY	$9.6 - $22.85 $61,132 - $145,508	6,368 New	6,368 $73,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $109M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.